Ligand Pharmaceuticals | LGND - EPS - Lucro por Ação

Preço das Ações
213.21
Mudança Diária
-5.77 -2.63%
Mensal
-4.49%
Anual
103.95%
Q2 Previsão
216.83

Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 1.63 1.82 1.33 May/07
FY2025Q4 Dec/2025 2.02 1.49 1.27 Feb/26
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06
FY2025Q2 Jun/2025 1.60 1.43 1.40 Aug/07
FY2025Q1 Mar/2025 1.33 1.22 1.20 May/08




Eps Alterar Data
Agenus USD -0.3 0.84 2025-12
Amgen USD 5.15 0.14 2026-03
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -0.93 1.15 2026-03
Baxter International USD 0.36 0.08 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Enviri Corporation USD -1.02 0.92 2025-12
Gilead Sciences USD 2.03 0.17 2026-03
GlaxoSmithKline GBP 0.43 0.17 2026-03
Glaxosmithkline GBP 0.62 0.41 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -0.76 0.78 2026-03
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Karyopharm Therapeutics USD -2.22 2.07 2025-12
Ligand Pharmaceuticals USD 1.63 0.39 2026-03
MacroGenics USD -0.58 0.36 2026-03
Merck USD -1.28 3.32 2026-03
Pacira USD 0.6 0.54 2026-03
Pfizer USD 0.75 0.09 2026-03
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Veracyte USD 0.52 0.01 2026-03